Adam Taich's most recent trade in 10x Genomics Inc - Ordinary Shares - Class A was a trade of 106,579 Class A Common Stock done . Disclosure was reported to the exchange on Feb. 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 10x Genomics Inc (Class A) | Adam S. Taich | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 106,579 | 394,996 (1%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc (Class A) | Adam S. Taich | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.58 per share. | 23 Feb 2026 | 8,968 | 288,417 (1%) | 0% | 18.6 | 166,593 | Class A Common Stock |
| 10x Genomics Inc (Class A) | Adam S. Taich | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 19.00 per share. | 24 Nov 2025 | 11,888 | 297,385 (1%) | 0% | 19.0 | 225,852 | Class A Common Stock |
| 10x Genomics Inc (Class A) | Adam S. Taich | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.79 per share. | 22 Aug 2025 | 22,315 | 309,273 (1%) | 0% | 13.8 | 307,657 | Class A Common Stock |
| 10x Genomics Inc (Class A) | Adam S. Taich | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.30 per share. | 22 May 2025 | 4,044 | 331,588 (1%) | 0% | 8.3 | 33,562 | Class A Common Stock |
| 10x Genomics Inc (Class A) | Adam S. Taich | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2024 | 201,704 | 201,704 (0%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc (Class A) | Adam S. Taich | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2024 | 133,928 | 335,632 (1%) | 0% | 0 | Class A Common Stock | |
| SomaLogic Inc - Ordinary S... | Adam Taich | Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 855,000 | 855,000 | - | - | Employee Stock Option (Right to Buy) | |
| SomaLogic Inc - Ordinary S... | Adam Taich | Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 592,000 | 592,000 | - | - | Restricted Stock Unit (RSU) |